Skip to main content

Table 3 Postoperative outcomes

From: Impact of frailty on inpatient outcomes in thyroid cancer surgery: 10-year results from the U.S. national inpatient sample

 

All patients

(n = 38,202)

Non-frailty

(n = 37,900)

Frailty

(n = 302)

p-value

In-hospital death

   

< 0.0001

 Alive

38,138

(99.83%)

37,847

(99.86%)

291

(96.36%)

 

 Dead

64

(0.17%)

53

(0.14%)

11

(3.64%)

 

Prolonged LOS

   

< 0.0001

 N (<75th percentile) (< 2 days)

22,932

(60.03%)

22,892

(60.40%)

40

(13.25%)

 

 Y (> = 75th percentile) (> = 2 days)

15,270

(39.97%)

15,008

(39.60%)

262

(86.75%)

 

Surgical complications

5388

(14.10%)

5253

(13.86%)

135

(44.70%)

< 0.0001

 Tracheostomy

38

(0.10%)

33

(0.09%)

5

(1.66%)

< 0.0001

 Hoarseness

270

(0.71%)

260

(0.69%)

10

(3.31%)

< 0.0001

 Hemorrhage, hematoma, or seroma

784

(2.05%)

734

(1.94%)

50

(16.56%)

< 0.0001

 Hypocalcemia

3587

(9.39%)

3540

(9.34%)

47

(15.56%)

0.0007

 Vocal cord paresis or paralysis

921

(2.41%)

866

(2.28%)

55

(18.21%)

< 0.0001

 Wound/ Technical complications

453

(1.19%)

427

(1.13%)

26

(8.61%)

< 0.0001

Medical complications

2690

(7.04%)

2523

(6.66%)

167

(55.30%)

< 0.0001

 Cardiovascular

1672

(4.38%)

1600

(4.22%)

72

(23.84%)

< 0.0001

 Pulmonary

521

(1.36%)

450

(1.19%)

71

(23.51%)

< 0.0001

 Acute kidney injury

190

(0.50%)

155

(0.41%)

35

(11.59%)

< 0.0001

 Pneumonia

604

(1.58%)

515

(1.36%)

89

(29.47%)

< 0.0001

 Infection/Sepsis

397

(1.04%)

336

(0.89%)

61

(20.20%)

< 0.0001